Positive results from the RESPECT Trial of transcatheter patent foramen ovale (PFO) closure vs. standard medical therapy ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 05, 2012
November 5, 2012 — Edwards Lifesciences Corporation announced three-year results of a pivotal clinical study of ...
November 05, 2012November 2, 2012 – A clinical trial that compared catheter-based PFO closure using an investigational device found that ...
November 02, 2012Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
November 2, 2012 — Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
November 02, 2012
November 1, 2012 — Medtronic Inc. announced promising data from the Engager European Pivotal Trial for the ...
November 01, 2012
November 1, 2012 — Terumo Interventional Systems announced the nationwide availability of its new Pinnacle Precision ...
November 01, 2012Sponsored Content
Blog | Contrast Media Injectors
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
August 22, 2023
November 1, 2012 — InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be ...
November 01, 2012
October 31, 2012 — Boston Scientific Corp. received CE mark approval for the Synergy everolimus-eluting platinum ...
October 31, 2012
October 30, 2012 — Maquet Cardiovascular received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and ...
October 30, 2012Sponsored Content
Blog | Enterprise Imaging
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
August 10, 2023
October 30, 2012 — W. L. Gore & Associates responded to initial results reported in St. Jude Medical Inc.’s RESPECT ...
October 30, 2012
October 30, 2012 — Fractional flow reserve (FFR)-guided treatment was shown to be cost effective for guiding coronary ...
October 30, 2012
October 30, 2012 — Elixir Medical Corp. said enrollment is complete in its 120-patient, pivotal clinical trial ...
October 30, 2012Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
October 29, 2012 — Brainlab released Buzz Digital OR, which is designed to aid information integration for the surgical ...
October 29, 2012
October 26, 2012 — Covidien announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of ...
October 26, 2012
October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the ...
October 22, 2012